# FDA 483 - Brian C. DeBeaubien, M.D. - April 24, 2026

Source: https://www.keypedia.com/records/483/brian-c-debeaubien-md/9aec865e-e6bc-4b8d-8a04-c53bb6bae83f

> FDA 483 for Brian C. DeBeaubien, M.D. on April 24, 2026. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Brian C. DeBeaubien, M.D.
- Inspection Date: 2026-04-24
- Product Type: other
- Office Name: Division of Pharmaceutical Quality Operations III
- Summary: Brian C. DeBeaubien, M.D., a clinical investigator in Saginaw, MI, was cited for failing to conduct an investigation in accordance with the investigational plan. Specifically, required cultures were not performed for 8 out of 11 subjects as mandated by Protocol Section 8.1. This indicates a significant deviation from the study protocol.

## Related Officers

- [Stephen O. Agyemang](https://www.keypedia.com/people/stephen-o-agyemang/b420a55d-21ea-46c7-8400-a8f22ca9b423)

Company: https://www.keypedia.com/companies/brian-c-debeaubien-md/222dd1ca-5df0-4c3d-97cd-4b15cb6468c1

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iii/45bc2d0d-d731-4955-aeb5-59aa0b76e4f0